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      ABSTRACT 
Evolving out of a need to address growing concerns regarding current methods 
of tissue transplantation, the field of tissue engineering seeks to facilitate the 
regeneration of viable tissue through the use of cellular scaffolds.  The first aim of this 
thesis was to provide a summary of the current literature on advances in biomaterial 
synthesis and pertaining methods of stem cell delivery in tissue engineering.  
Improvements in the processing of decellularized tissue and the expansion of synthetic 
hydrogels as platforms for stem cell encapsulation have led to the development of 
extracellular matrix (ECM)-based hybrid hydrogels.  These stem cell scaffolds are 
currently being explored as biomaterials for the purpose of tissue regeneration. 
 The second aim of this thesis was to fabricate a hybrid synthetic/adipose-derived 
ECM hydrogel. Decellularized adipose tissue was incorporated, at varying 
concentrations, with a thiol-acrylate fraction that was then polymerized to produce 
hydrogels via a Michael addition reaction.  Hydrogels were characterized based on their 
ability to support the proliferation, maintain the viability and retain the multipotency of 
human adipose-derived stem cells (hASCs).  Cells encapsulated in hydrogels 
containing high concentrations of ECM demonstrated greater expression of human 
potency markers compared to cells encapsulated in ECM-free synthetic hydrogels or in 
Matrigel®, indicating that adECM hydrogels hold promise as a cost-effective platform for 
mesenchymal stem cell multipotency maintenance for tissue engineering applications.   
Inspired by the findings that adipose-derived ECM can be converted into a 
cytocompatible hydrogel after combination with a synthetic fraction, efforts were 
conducted in order to improve the performance of the hybrid synthetic/adipose-derived 
ECM hydrogel platform.  ECM was thiolated prior to hydrogel synthesis in order to 
promote more uniform dispersion. Thiolated adipose-derived ECM hydrogels were 
characterized based on their ability to maintain hASC viability.  It was found that hASCs 
seeded on hydrogels containing higher concentrations of thiolated adECM (tadECM) 
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demonstrated decreased viability compared to tadECM-free hydrogels.  As these results 
may be caused by incomplete thiol-acrylate conversion, increasing the thiol concentration 
of the tadECM prior to hydrogel synthesis may lead to improved outcomes.
 
1 
1. CURRENT BIOMATERIALS AND PERTAINING STEM CELL DELIVERY 
METHODOLGIES IN TISSUE ENGINEERING LITERATURE REVIEW 
 
       The field of tissue engineering seeks to regenerate viable tissue through the use of 
cell-scaffold systems.  When employing stem cells for the generation of functional 
tissue, these scaffolds have the potential to promote cellular expansion and to affect 
cellular lineage commitment.  This brief review aims to provide insight into the various 
types of biomaterials used for cell scaffold synthesis.  In addition, this work offers a 
summary of the considerations for stem cell scaffold design, pertinent methods 
employed for stem cell delivery, and examples of current stem cell scaffold systems. 
 
1.1  Tissue Engineering, Mesenchymal Stem Cells, and Cellular Scaffold Design 
 
       Every day, thousands of surgical procedures are performed to replace or repair 
damaged or injured tissue.1  Evolving out of a need to address concerns pertaining to 
tissue transplantation, including the limited availability of healthy tissue, the field of 
tissue engineering seeks to facilitate the generation of viable tissue though the 
combination of cells and a cellular scaffold.1,2  Mesenchymal stem cells (MSCs) are 
multipotent stromal cells most commonly derived from adult bone marrow or adipose.3  
Due to their ability to be easily grown and selectively differentiated in vitro, MSCs are 
widely used in the field of tissue engineering.4  It has been demonstrated that MSCs 
have the ability to differentiate into a variety of cell types, including adipocytes,5 
mycoytes,4 osteoblasts,6 and chondrocytes.7   To date, two dimensional (2D) cell 
culture has been the most common platform for in vitro culture of MSCs.  However, 
cellular differentiation and tissue development is a three-dimensional (3D) process—
native cells interact with each other, the ECM, and their surrounding microenvironment 
in a 3D fashion.8  The additional dimensionality influences the spatial organization of 
cell surface proteins, which ultimately effects gene expression and cellular behavior.9  
In addition, 3D conditions modulate the transport of nutrients, gases, and effector 
proteins differently than a 2-D environment.10  As a result, cells cultured in a 3D 
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environment differ genetically, physiologically,11 and morphologically from cells cultured 
in 2D.12  The inability of 2D culture to accurately model the 3D environment of native 
tissue has motivated the development of 3D cellular scaffolds for cell-based studies in 
the fields stem cell research and tissue regeneration.  
       Tissue engineering scaffolds can be divided into three distinct groups of 
biomaterials—ceramics, synthetic polymers, and natural polymers.  The ideal stem cell 
scaffold fulfills several design requirements.  First, the scaffold is biodegradable, 
meaning that it is able to be broken down in vivo, preferably at the same rate as host’s 
cells’ colonization of the scaffold.13  Secondly, the biomaterial should be 
cytocompatible, meaning cells function normally once they adhere to or are 
encapsulated in the scaffold.14  The material should also be broadly biocompatible and 
its by-products should also evoke a minimal host response, once implanted, as to not 
cause rejection of the implant by the host or inhibit the healing process.15,16  
Additionally, the biomaterial’s mechanical properties should closely match that of the 
tissue surrounding the defect site.17  Furthermore, the morphology and structure should 
incorporate interconnected pores to facilitate cell proliferation, nutrient diffusion, and 
waste removal.18  Pores should be small enough to maintain a high specific surface 
area, allowing for efficient cellular adhesion, but large enough to facilitate cell migration 
through the scaffold.19  Moreover, in order to become commercially and clinically 
sustainable, scaffold synthesis methods should have the ability to be translated into 
reproducible and robust manufacturing processes.20  Finally, scaffolds designed for 
stem cell colonization should be able to effectively direct desired cellular fate. 21 To 
date, numerous varieties of scaffolds have been used in combination with MSCs in an 







1.2  Naturally-Derived Biomaterials for Tissue Engineering 
 
1.2.1  Commonly Used Naturally-Derived Polymers 
       The need for biodegradable and biocompatible materials to act as stem cell 
scaffolds has led to the widespread use of naturally-derived biomaterials for tissue 
regeneration.  These biomimetic scaffolds can be categorized as either protein-based or 
polysaccharide-based polymers. Due to their capacity to mimic native extracellular 
matrix (ECM), protein-derived polymers, such as gelatin,22 collagen,23 fibrin,24,25 and 
silk,26 have the potential to support cellular organization, migration, and proliferation 
during the process of tissue generation.  For example, El-Jawhari et al. demonstrated 
that the incorporation of collagen into bone marrow-derived MSC scaffolds significantly 
improved cellular attachment and proliferation in vitro.27 
       Alternatively, polysaccharide-derived polymers can be obtained from microbial, 
vegetal, or animal sources.28  It has been demonstrated that these biomaterials, such 
as hyaluronan,29 chitosan,30 starch,31 and alginate,32 have the capacity to maintain 
cellular viability and support stem cell differentiation. Yoon et. al found that hyaluronic 
acid-based scaffolds supported chondrogenic differentiation of adipose-derived MSCs 
cultured with bone morphagenic protein-2 (BMP-2).33  In addition, polysaccharide-
derived polymers have low toxicity and can be produced relatively inexpensively.34,35 
However, although naturally-derived biomaterials have been widely used as stem cell 
scaffolds, their poor mechanical tunability and sometimes high batch-to-batch variation 
has led to further research aimed at addressing these shortfalls.36       
1.2.2  Decellularized Tissue Scaffolds 
       The ECM of the human body is a gel-like, fibrous network that provides mechanical 
support and biochemical cues to cells that makeup the body’s tissues.37,38  ECM—
which includes structural proteins, growth factors, proteoglycans, glycosaminoglycans, 
and proteolytic enzymes—has been implicated in cellular proliferation, differentiation, 
morphogenesis, adhesion, and migration.39  The recognition of ECM as being integral 
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to directing stem cell behavior has led to the production and use of scaffolds derived 
from decellularized tissue.  These protein-based biomaterials offer the capability to 
simulate the role that native ECM plays in the process of tissue generation.  Once tissue 
is harvested from allogeneic or xenogeneic donors,40 it is decellularized, often using 
detergents,41 chemical agents,42 enzymes,43 or a combination of these.44  Nucleases 
and detergents may also be utilized to remove residual DNA.45,46  Removing the 
donor’s cells and cell remnants from the scaffold allows for a drastically lessened host 
immune response, post-implantation, compared to current organ transplant 
procedures.47  For some applications, such as whole-organ scaffolds, in which 
preserving ECM structure and bioactivity are paramount,48 tissue processing ends after 
decellularization.  However, in instances when ECM derivatives, such as structural 
proteins, are required for scaffold synthesis, tissues are further digested, typically by 
employing chemical or enzymatic methods.49,50  It has been shown that tissue can be 
decellularized and processed in such a way that the risk of an adverse host immune 
response is minimized while scaffolds largely maintain their bioactivity profile.51,52  
Such scaffolds have been used to facilitate the regeneration of multiple types of 
functional tissues.53,54 Table 1.1 demonstrates current clinical products that are 
composed of decellularized tissues.55  Although ECM-derived scaffolds offer the 
capability to serve as highly bioactive grafts, like many other naturally-derived scaffolds, 
their relatively limited mechanical adjustability and batch-to-batch variation hinders their 










Table 1.1 - Clinical products composed of decellularized tissue.55   
 
Product Tissue Source Application Focus 
Alloderm® Human dermis Soft tissue 
Strattice™ Porcine dermis Soft tissue 
Zimmer Collagen Repair Patch™ Porcine dermis Soft tissue 
TissueMend®  Bovine dermis Soft tissue 
Oasis®, Surgisis® Porcine small intestine Soft tissue 
Restore™ Porcine small intestine Soft tissue 
FortaFlex® Porcine small intestine Soft tissue 
Meso BioMatrix™ Porcine mesothelium Soft tissue 
MatriStem®  Porcine urinary bladder Soft tissue 
GraftJacket® Human dermis Soft tissue, chronic wounds 
OrthAdapt®, Unite® Equine pericardium Soft tissue, chronic wounds 
NeoForm™ Human dermis Breast 
AlloPatch HD™, FlexHD® Human dermis Tendon, breast 
CopiOs® Bovine pericardium Dentistry 
Lyoplant® Bovine pericardium Dura mater 
CorMatrix ECM™ Porcine small intestine Pericardium, cardiac tissue 
Perimount® Bovine pericardium Valve replacement 
Hancock® II, Mosaic®, 
Freestyle® 
Porcine heart valve Valve replacement 
Prima™ Plus Porcine heart valve Valve replacement 




1.3  Synthetic Hydrogels and Stem Cell Encapsulation in Tissue Engineering 
 
1.3.1  Synthetic Hydrogels 
       Hydrogels are hydrophilic materials, composed of one or more monomers, that 
have the ability to retain relatively large amounts of water without dissolving.58  Their 
largely aqueous makeup is considered to be integral to their capacity to be 
biocompatible.59  Hydrogels can be constructed using either synthetic or naturally-
derived materials and can be polymerized via chemical or physical crosslinking.60-63  
Commonly used synthetic monomers for hydrogel synthesis include polyethylene glycol 
(PEG),64 polyvinyl alcohol (PVA),65 and polyacrylamide (PAM).66  These hydrogels 
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can be engineered to be permeable to small molecules, such as gases, low molecular 
weight metabolites, and ions.67  This allows cells encapsulated in the material to 
receive nutrients and oxygen, and for removal of waste to take place.68  In addition, 
due to their large number of polar reactive sites, synthetic hydrogels have the ability to 
anchor biologically active molecules.69  This versatility has allowed researchers to 
modulate the adhesion, migration, and proliferation of mesenchymal stem cells cultured 
on or within synthetic hydrogels for the purpose of tissue regeneration.70,71  Hydrogels 
created using synthetic polymers also have largely-tunable mechanical 
characteristics.72,73  This makes them an attractive tool for stem cell culture in that 
substrate-level elasticity plays a significant role in stem cell fate.74  Therefore, as 
Engler et. al demonstrated, by modifying substrate stiffness, it is possible to control 
mesenchymal stem cell lineage and commitment.74  As such, there has been an 
increase in research dedicated to the development of synthetic hydrogels as functional 
3D stem cell scaffolds due to their ability to be finely adjusted in terms of composition 
and mechanical behavior. 
1.3.2  Stem Cell Encapsulation in Synthetic Hydrogels 
 
       In the utilization of hydrogels as platforms for tissue regeneration, there are two 
common methods of stem cell seeding that are generally employed.  One strategy is to 
seed stem cells on the scaffold surface, allowing them to adhere to the porous 
structure.75  In this scenario, hydrogels are prefabricated, allowing researchers to use a 
wider range of polymerization methods, as long as the resultant scaffold is 
cytocompatible.75  Alternatively, cells may be encapsulated within the hydrogel 
precursor solution prior to polymerization.76  This approach necessitates that suitable 
materials and bioorthogonal chemical reactions be used in the polymerization process 
in order to maintain cellular viability and functionality.77  However, cell encapsulation 
has several benefits in in vivo applications.  First, hydrogel precursor solutions have the 
potential to be injected into a tissue defect site instead of being cast into a desirable 
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shape prior to implantation.78  In addition, as opposed to requiring sutures or glue, an 
injected solution has the ability to diffuse through nearby tissue for effective adhesion.79  
Optimally, scaffold design should allow for in vivo degradation of the hydrogel to 
progress at the same rate as tissue regeneration.8  
       Largely due to its relative stability in vivo,80 PEG has been the most widely used 
synthetic monomer for hydrogel encapsulation.75  It also has ability to be easily 
functionalized, allowing for polymer crosslinking density, and therefore, its mechanical 
properties, including degradation rate, to finely controlled.81,82  From a bioactivity 
perspective, however, PEG hydrogels are relatively inert.83  Alone, their inability to 
mimic bioactive molecules in the native ECM significantly limits their capacity to 
promote tissue regeneration.84 
1.4  ECM-based Hybrid Hydrogel Scaffolds 
       In an effort to construct a 3D scaffold that combines the bioactivity of native tissues 
with the mechanical adjustability of synthetic hydrogels, researchers have designed 
hybrid hydrogels to promote stem cell proliferation and differentiation.  While some 
investigations have been directed towards combining natural polymers, such as alginate 
and collagen,85,86 with synthetic fractions, numerous studies have employed synthetic 
oligopeptides to promote cellular attachment and proliferation.87-89  These designer 
peptides, which often contain the Arginylglycylaspartic acid (RGD) motif, are commonly 
conjugated to synthetic polymers using bioorthogonal chemical reactions, resulting in a 
functionalized hydrogel.90,91  Although the incorporation of designer peptides into 
hydrogels offers a convenient means of introducing a level of bioactivity into an otherwise 
inert scaffold platform, synthetic peptides deliver a relatively limited source of biologic 
information to adherent cells.92,93  As a result, they are unable to fully recapitulate 
proteins found in the native ECM.94  In addition, designer peptides can be costly to 
produce in substantial quantities.95  Therefore, due to its potential to mimic native ECM, 
there is an area of research dedicated to the integration of decellularized tissue and its 
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derivatives into synthetic hydrogels.  Notably, Grover, et. al demonstrated that 
decellularized myocardial matrix could be combined with PEG to promote cellular 
migration and adhesion.96 Furthermore, Visser et. al showed that a blend of 
decellularized cartilage, meniscus, and tendon tissue could be functionalized and 
integrated with a gelatin methacrylamide hydrogel to affect chondrogenic differentiation 
in encapsulated MSCs.97  These studies indicate that ECM-based hybrid hydrogels have 
the potential to affect stem cell differentiation, and therefore, tissue regeneration, by 
means of a biologically complex, mechanically tunable scaffold.  
1.5  Future Work and Conclusion  
       While the field of tissue engineering has seen rapid progression in the evolution of 
biomaterials, there remains a need for further development of stem cell scaffolds that 
can accurately recapitulate the structural and physiological aspects of native ECM. The 
notable advancements in cellular culture, scaffolds, and integration methods reviewed 
here have the potential to lead to groundbreaking clinical products that promote 















2.  IN VITRO EVALUATION OF HYBRID SYNTHETIC/ADIPOSE-DERIVED 
ECM HYDROGELS AS A CULTURE PLATFORM FOR HUMAN ADIPOSE-DERIVED 
STEM CELLS 
 
2.1  Project Purpose 
       There is a distinct need in the field of tissue engineering for a three-dimensional 
scaffold that has the ability to maintain the multilineage differentiation capacity of 
mesenchymal stem cells.  Human adipose tissue offers an abundant source of allogenic 
material that contains ECM proteins, peptides, and glycosaminoglycans.  When 
decelluarized and combined with a mechanically tunable polymer, these ECM 
components offer the potential to recapitulate the stem cell niche in a more cost-effective 
manner than commonly used synthetic peptides.  As described herein, human 
decelluarized adipose tissue were incorporated, at varying concentrations, with a thiol-
acrylate fraction that was then polymerized to produce hydrogels via a Michael addition 
reaction.  These hydrogels were characterized based on their ability to support the 
proliferation, maintain the viability and retain the multipotency of human adipose-derived 
stem cells (hASCs).  It was found that hASCs encapsulated in hydrogels containing high 
concentrations of adipose-derived ECM (adECM) displayed increased expression of 
potency markers for a longer duration relative to cells encapsulated in Matrigel® or 
adECM-free PEG hydrogels.  These results indicate that adECM hydrogels hold promise 
as a cost-effective platform for mesenchymal stem cell multipotency maintenance for 
tissue engineering applications.   
2.2  Introduction   
       From the time that mesenchymal stem cells were discovered and used clinically, 
there has been a need to expand cells in a native 3D conformation while also maintaining 
stem cell potency for future use. Corning® Matrigel® Matrix revolutionized stem cell culture 
when it was first widely distributed. However, nearly 30 years later, clinicians and 
scientists still rely on Matrigel® to grow and expand stem cells in 3D.  While Matrigel® has 
paved the way for many discoveries, it is still unclear what signaling molecules are present 
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within the hydrogel. In addition, Matrigel® cannot be mechanically or functionally tuned, 
and there is a high batch-to-batch variability. 
       Hydrogels’ high water content in addition to their highly tunable functional groups, 
degradation schemes, and mechanical properties make them widely used as 3D cellular 
scaffolds for stem cell potency maintenance and expansion.98,99 Researchers have 
exploited this versatility, combined with synthetic peptides to develop biomimetic 
hydrogels that provide microenvironments similar to those observed in native cell 
niches.100-105  Extensive research has shown that the structure and content of such 
hydrogels can play a critical role in determining cell fate. Synthetic peptides have a 
substantial advantage as they are reproducible and can be easily modified for 
incorporation into hydrogel networks. However, synthetic peptides are very expensive to 
synthesize and purify, limiting the scope and scale of potential applications. As such, 
there has been a surge in research dedicated to the development of scaffolds, namely 
hydrogels, derived from naturally occurring biological materials. There is evidence that 
suggests that these natural biomaterial-laden scaffolds provide a marked increase in 
biocompatibility and bioactivity.100,106-109 Incorporation of extracellular matrix (ECM) 
isolated from decellullarized tissues in hydrogels has been of particular interest. Cell 
adhesion, growth, proliferation, differentiation, and cell fate are heavily dependent on the 
signaling molecules and immobilized proteins contained within surrounding ECM.110-111  
Many researchers have used detergents, enzymes, and mechanical forces to remove 
cellular material while retaining proteins and bioactive molecules.109,112  Processed 
ECM can then be incorporated into a synthetic scaffold to create a highly tunable 
construct with biological components. Such scaffolds have shown success in facilitating 
the regeneration of functional tissue.113,114 
       Adipose tissue from lipoaspirate is clinical waste that can be used as allogenic 
material for the development of ECM-laden constructs. Adipose contains various ECM 
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components, such as collagen, reticular fibers, elastin fibers, nerve fibers, vascular 
stroma, lymph nodes, and endocrine and paracrine signaling 
molecules.113  Subcutaneous adipose tissue provides a readily accessible source of 
allogeneic material, as many healthy individuals electively seek out plastic and 
reconstructive surgical procedures to remove unwanted subcutaneous adipose tissue via 
liposuction or abdominoplasty. The majority of this human tissue is discarded as medical 
waste.  Our preliminary results  have documented the reproducible ability to decellularize 
and extract human adipose tissue ECM (adECM).  An evaluation of adECM revealed its 
key compositional qualities. Analysis of the peptide fragments by mass spectroscopy 
identified 77 individual proteins in the adECM.  Nearly 50% of these proteins were 
associated with either the extracellular space or the plasma membrane and included 
multiple collagen family members. Of the remainder, over 37% had cytoplasmic 
associations while ~8% were of nuclear origin. Overall, the adECM proteins identified 
were consistent with earlier proteomic analyses of adipose derived cells and 
tissues.111,115  Therefore,  the reliable incorporation of adECM into a synthetic scaffold 
has the potential to be a more cost effective alternative to current commercial peptide-
based products. 
       In this study, we present the synthesis of a hybrid ECM-laden hydrogel to be used as 
a 3D scaffold to support human adipose-derived stem cell (hASC) growth and maintain 
cellular potency. The adECM was incorporated into a synthetic thiol-acrylate polymer 
fraction and polymerized via a base-catalyzed Michael Addition reaction. Modulation of 
the reaction conditions affects polymer crosslinking. As such, the Michael Addition 
provides the ability to tune the mechanical properties of the polymer fraction, the 
component chiefly responsible for the mechanical properties and the degradation profile 
of the hydrogel. The adECM, obtained by decellularizing lipoaspirate as described by 
McIntosh et. al., was utilized for its array of bioactive molecules and availability.21  The 
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integration of adECM with a synthetic polymer provides a dynamic environment that 
fosters active cellular responses. 
       Thiol-acrylate hydrogels laden with varying amounts of adECM were synthesized and 
compared. The mechanical properties of each hydrogel were characterized via 
compression testing to determine Young’s modulus. Swelling experiments were 
conducted to determine swell ratio, cross-link mesh size, and mass loss behavior. Human 
adipose-derived stem cells (hASCs) were encapsulated within each hydrogel prior to 
polymerization. Cell viability,proliferation, and morphology were evaluated via CCK-8 
metabolic assay, Click-iT®Plus EdU assay, and F-actin staining.  Maintenance of cell 
pluripotency was measured via Q-RT-PCR of the human pluripotency genes SOX2 and 
NANOG. 
2.3  Materials and Methods 
2.3.1  Cell Culture 
       hASCs were isolated from lipoaspirate obtained from LaCell LLC (New Orleans, 
LA).  Extracts of subcutaneous adipose tissue were acquired from three consenting 
donors undergoing elective plastic surgery under a protocol approved by either the 
Pennington Biomedical Research Center Review Board (Baton Rouge, LA) or Western 
Institutional Review Board (Puyallup, WA). hASCs were isolated as previously 
described.116  hASCs were maintained in T125 flasks at 37˚C at 5% CO2 in a humidified 
atmosphere.  Cells were allowed to grow until 80% confluent.  Second passage (P2) cells 
were used in the extraction, DNA synthesis, and quantitative reverse-transcript PCR (qrt-
PCR) studies.      
2.3.2  ECM Decellularization 
       Adipose tissue (~100g) from two consenting donors (LaCell LLC, New Orleans, LA) 
was placed in 200 mL of 3.4 M sodium chloride (NaCl) buffer for 1 hour. The tissue was 
then homogenized in solution using an an electric homogenizer (Omni Ultra Shear Small 
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Volume).  Fibrous tissue that could not be mechanically homogenized was continuously 
removed and collected, while all other tissue components were disregarded as 
waste.  100 mL of 2 M urea buffer was added to the collected fibrous tissue, and the 
solution was refrigerated for 48 hours. The urea/fibrous tissue solution was then 
centrifuged three times at 23,000 g at 4 ˚C for 20 minutes.  After each centrifugation, the 
pelleted tissue was collected and the solvent was discarded as waste. The fibrous pellet 
was then dialyzed against deionized water for 24 hours before digestion with 0.5% (w/v) 
pepsin in 0.5 M acetic acid.  After completion of the digestion reaction, the pepsin was 
deactivated by raising the pH of the solution to 9.0 using 1 M sodium hydroxide 
(NaOH).  The solution was then incubated overnight at 37 ˚C, followed by lowering the 
pH of the solution to 7.4 with 1 M hydrochloric acid (HCl).  The neutralized solution was 
dialyzed again against deionized water for 24 hours before being flash-frozen and 
lyophilized to yield a adipose-derived extracellular matrix (adECM) powder. The adECM 
powder was gas sterilized with ethylene oxide prior to use. 
2.3.3  Protein Quantification 
       The Pierce™ BCA Assay (ThermoFisher Scientific, USA) was used to determine the 
total protein content in ECM samples. Briefly, diluted aliquots (10 μL) were removed (n=3) 
from processed ECM and incubated with assay reagents for 30 min at 37 ℃ in a 96-well 
plate in accordance with the Pierce™ protocol. The plate was then cooled to room 
temperature and absorbance was measured at 532 nm using a fluorescence plate reader 
(Wallac 1420 multilabel HTS counter). 
2.3.4  Proteomics Analysis  
       In order to characterize the adECM, liquid chromatography-mass spectroscopy (LC-
MS) was performed.  Samples were prepared by combining 15 µL digestion buffer (8 
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mg/mL ammonium bicarbonate in water), 3 µL reducing reagent (30 mg/mL TCEP), and 
12 µL sample solution containing 7 µg lyophilized adECM powder or 12 µg BSA standard 
protein (total volume 30 µL). The sample was then reduced using TCEP (30 mg/mL) at 
50˚C for 7 min, and cooled to room temperature, before being centrifuged to collect the 
sample.  3 ul alkylating reagent (18mg/mL iodoacetamide in digestion buffer) was added 
to the sample and it was incubated in the dark at room temperature for 20 min.  Finally, 3 
µL proteomics grade trypsin, activated with ammonium bicarbonate (0.1 µg/µL), was 
added to the sample and it incubated at 37 ˚C for 3 hours and stored at -20 ˚C.  LC-
MS/MS analysis was performed using Thermo Finnigan’s ProteomeX workstation LTQ 
linear ion trap MS (Thermo Electron, USA). 12 mL of sample was injected into a peptide 
trap cartridge (Agilent, USA). The sample was eluted onto a 10-cm reverse-phase Pico 
Frit column packed in house with 5 µm, 300 Å pore size C18, and then separated on an 
RP column by gradient elution. The mobile phases were H2O (A) and ACN (B), both of 
which contained 0.1% (v/v) formic acid. The flow rate was maintained at 200 nL/min. The 
gradient was started at 2% B, reached 60% B in 50 min, 80% B in the next 5 min, and 
then 100% A in the final 15 min. Data-dependent acquisition mode (m/z 300-1800) was 
enabled, and each survey MS scan was followed by five MS/MS scans with the 30 s 
dynamic exclusion option enabled. The spray voltage was 1.9 kV and the temperature of 
the ion transfer tube was set at 195 °C. The normalized collision energy was set at 
35%.  Samples were acquired in triplicates.  
2.3.5  Fabrication of adECM Hydrogels 
       Hydrogel reagents were reacted together employing a thiol-ene base-catalyzed 
Michael addition reaction with a 1:1 functional ratio of acrylate to thiol. adECM proteins in 
phosphate buffered saline (PBS) were preincubated for 30 minutes with PEG-acrylate 
monomers at various concentrations (w/v%) (0%, 0.01%, 0.1%, and 1%).  During 
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preincubation, a solution of PBS, ethoxilated-trimethylolpropan tri(3-mercaptopropionate) 
(ETTMP 1300, and 1 M NaOH were reacted together in a separate tube. After incubation, 
the PEG-acrylate and adECM solution was mixed with the ETTMP 1300 and NaOH 
solution. Gelation occurred in less than one minute, and could be controlled by altering 
the temperature and the amount of NaOH. 
2.3.6  Analysis of adECM Distribution  
       Hydrogels of various concentrations (0%, 0.01%, 0.1%, 1%) were embedded in 
O.C.T for cryosectioning, and stained with Masson’s Trichrome staining kit using the 
manufacturer’s protocol. Briefly, the cryosection was stained in working Weigert’s iron 
hematoxylin solution for 30 s and washed in deionized (DI) water for 5 min.  It was then 
placed in biebrich scarlet–acid fuchsin for 5 min. After being rinsed in DI water, the slides 
were placed in a phosphomolybdic acid/ phosphotungstic acid solution for 10 min and 
then in an aniline blue solution for 7 min. After rinsing briefly DI water, the sections were 
placed in a 1% acetic acid solution for 30 s.  Slides were then dehydrated and mounted. 
Images were taken using a BX51 Olympus microscope.  Collagen distribution was 
measured and analyzed via color counting software (Photoshop CS5, Adobe, 
USA).117  Each sample was randomly measured in five different positions and four total 
samples were included for analysis (n=20). 
2.3.7  Mechanical Testing 
       Hydrogels with protein additives (0%, 0.01%, 0.1%, and 1%) were formed using a 5 
mm (height) × 10 mm (diameter) cylindrical mold and allowed to swell overnight before 
being tested to determine elastic modulus and maximal compressive strength.118  The 
results reported (n=5) were taken with 80% strain at a compression rate of 1 mm/min from 
an Instron Mechanical Test System 5696 using an Instron 2 kN static load cell (Instron 




2.3.8  Swelling and Mass Loss Experiments 
       Four sets of hydrogels with varying adECM content (0%, 0.01%, 0.1%, 1%) (w/v) 
were polymerized via base-catalyzed Michael addition as described above. Upon 
formation, hydrogels (135 µL) were incubated at 37 ˚C in 1 mM PBS, pH 7.4. At 0 h, 12 
h, 24 h, 48 h, 72 h, 120 h, and 168 h, hydrogel samples were collected, pat dry, and their 
mass after swelling (𝑀") was recorded. The hydrogel samples were then lyophilized 
overnight, and their dry mass was recorded (𝑀#). Hydrogel swelling ratio (𝑄%) was then 




   (Eq. 2.1) 
 
QM was then used to calculate the volume swelling ratio (QV) using Eq. 2.2 below:       
𝑄) = 1 +
,-
,'
(𝑄% − 1)   (Eq. 2.2) 
Where (𝜌2)  is the density of PEG-acrylate (1.12 g/cm3 ) and  is the density of the solvent 
(𝜌") (1.0 g/cm3  for PBS). 
Mass Loss percentage (𝑀. 𝐿.%) was determined using the Eq. 2.3 below: 
𝑀. 𝐿.% = %'6%(
%(
   (Eq. 2.3)        
 
2.3.9  Viability Of hASCs After Acute Exposure To Hydrogel Extracts 
       The cytotoxic effects of scaffold degradation products were evaluated using Cell 
Counting KitTM (CCK-8) (Dojindo Molecular Technologies), a commonly used assay to 
measure cell viability and proliferation.  Following scaffold incubation periods of 7 and 14 
days, extracts were filtered. hASCs were seeded at a density of 91 cells/mm2 for 24 hours 
in stromal media (DMEM-F12, 10% FBS, 1% Penicillin-Streptomycin-Amphotericin B 
solution).  The media was replaced with hydrogel extract. hASCs cultured in stromal 
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media served as a positive control.  After 24 hour incubation at 37 ºC and 5% CO2, 100 
µL of 10% CCK-8 solution were added to each well and samples were incubated at 37 ºC 
for 12 hours.  The absorbance was measured at 460 nm using a plate reader (Wallac 
1420 multilabel HTS counter) and the cell viability was normalized based on the standard 
curve.     
2.3.10  Encapsulation and Culture of hASCs with Synthetic adECM Hydrogel 
       hASCs were encapsulated in the scaffolds at 1 x105 cells / mL.  Hydrogels were 
formed in a 96-well plate at a volume of 45 μL and were polymerized at 37 °C to ensure 
cell suspension and survivability.  Encapsulated cells were cultured in growth media 
(Dulbecco's modified Eagle's medium [DMEM/F12], 10% fetal bovine serum [FBS], and 
1% Penicillin-Streptomycin-Amphotericin B solution) for up to 14 days with media 
maintenance performed three times a week. 
2.3.11  EdU Staining 
       Encapsulated hASCs were characterized based nuclear morphology, and DNA 
synthesis rate.  In accordance with iClick EdU Andy Fluor 555 Imaging Kit (Genecopoeia) 
instructions, the nuceloside analog, EdU (5-ethynyl- 2´-deoxyuridine), was introduced to 
culture media four days prior to cell fixation.  At 7 and 14 days, scaffolds were fixed in 4% 
paraformaldehyde, rinsed three times with PBS, and permeabilized using .5% Triton X-
100 in PBS.  Scaffolds were stained following iClick EdU Andy Fluor 555 Imaging Kit 
protocol instructions.  To assess nuclear morphology, scaffolds were stained in a 5 μM 
DRAQ5 solution (Life Technologies).  Scans for DRAQ5 fluorescence (Exmax 647, 
Emmax681), and Andy Fluor 555 fluorescence (Exmax 555, Emmax565)  were performed with a 
white light laser at 641 nm and 519 nm, respectively, in the sequential scanning mode at 
1024 x 1024 pixel resolution using a 20x objective (HC PL APO CS2 20x/ .70 1mm; Leica, 
Bensheim, Germany).  Images were brightened uniformly using Adobe Photoshop CC 
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2017. Previously described methods were employed to quantify hASC proliferation rate 
(n=5).23  Briefly, the Photoshop thresholding tool was used to obtain a cut-off intensity in 
images taken at 641 nm (DRAQ5) and 519 nm (Andy Fluor 555).  Pixels above the cut-
off intensity in groupings with areas greater than 7 μm were considered stained.  The 
number of Edu-stained cells was divided by the number of DRAQ5-stained cells to obtain 
DNA synthesis rate. 
2.3.12  F-Actin Staining 
       To assess cytoskeletal shape, scaffolds were stained in a 200 nM F-actin 488 
solution (Life Technologies).   Scaffolds were rinsed before being mounted on PBS on a 
glass slide and imaged using a Leica TCS SP8 confocal laser scanning 
microscope.  Scans for Alexa 488 fluorescence (Exmax 495, Emmax518), were performed 
using a a white laser at 460 nm at 1024 x 1024 pixel resolution using a 20x objective (HC 
PL APO CS2 20x/ .70 1mm; Leica, Bensheim, Germany).               
2.3.13  Quantitative Real-time Polymerase Chain Reaction 
       RNA was isolated from encapsulated scaffolds as previously described.119  In 
addition, RNA was purified using the PureLink® RNA Minin Kit in accordance with 
manufacturer’s instructions.  Total RNA to cDNA EcoDry Premix (ClonTech) was used 
for cDNA synthesis. qRT-PCR was performed using 2× iTaq SYBR green supermix with 
ROX (Biorad) and primers for SRY-related HMG-box (SOX2) and human NANOG 
(hNANOG) to quantify gene expression associated with maintenance of multipotency in 
hASCs encapsulated into hydrogels and cultured for 7 and 14 days. Reactions were 
performed with a MJ Mini Thermal Cycler (BioRad). The sequences of PCR primers 
(forward and backward, 5’−3’) were as follows: SOX2, 5'-
TACAGCATGTCCTACTCGCAG-3, and, 5' GAGGAAGAGGTAACCACAGGG-3’; 
hNANOG, 5’- ATGCCTCACACGGAGACTGT-3’ and 5’- GGGCTGTCCTGAATAAGCA-
3’.  Samples were normalized (ΔCt) against the housekeeping gene 18S rRNA (forward 
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and backward, 5’-3’): 5’-AAACGGCTACCACATCCAAG-3’ and 5’-
CCTCCAATGGATCCTCGTTA-3’.  The - ΔΔCt value of SOX2 and hNANOG in 
encapsulated polymers was calculated using the ΔΔCt method. 
2.3.14  Statistical Analysis 
       All results were expressed as mean ± standard deviation. Data were analyzed with 
one-way analysis of variance, followed by Tukey's minimum significant difference post 
hoc test for pairwise comparisons of main effects. For all comparisons, a p-value < 0.05 
was considered significant. 
2.4  Results 
 2.4.1  Hydrogel Synthesis 
       In this study, the effects of adECM hydrogels on encapsulated hASCs were 
evaluated. A schematic for adECM incorporation and hydrogel polymerization is 
































2.4.2  Liquid Chromatography-Mass Spectroscopy  
       LC-MS was used to characterize proteins found in adECM.  Three distinct proteins 
were identified (Table 2.1).  Collagen, type I, alpha 2 was found in all three of the 
samples.  Collagen, type I, alpha 1 was found in samples 1 and 3.  Finally,  collagen type 
III alpha 1 was identified only in sample 3 (Table 2.2). The results are consistent with 
other studies performed by Edwin C.M. et al.118   
2.4.3  adECM Distribution  
       Masson’s Trichrome staining was performed to investigate the distribution of adECM 
collagen in all adECM hydrogel compositions.  Significantly more collagen, stained blue, 
was found in the 1% adECM group , compared to the 0.1% adECM hydrogel, the 0.01% 
adECM hydrogel and the 0% adECM group (Figure 2.1)  In all samples, collagen, when 
present, appeared to be punctate and not uniformly distributed throughout the scaffold 
(Figure 2.2).   
 




















Figure 2.1 - Collagen content of adECM hydrogels.  All samples are statistically 
significant.    
  
 
Figure 2.2 - Masson’s Trichrome staining of adECM hydrogels. A, D) 1% adECM, B), E) 
0.1% adECM, C),  F) 0.01% adECM, G), F), H) 0% adECM.  Collagen is stained blue. 





2.4.4  Mechanical Characterization 
       Figure 2.3 shows the mechanical strength data for hydrogel scaffolds containing 
different concentrations of adECM.  Increasing adECM concentration, lead to a decrease 
in Young’s modulus. Hydrogels containing 0.01%, 0.1%, and 1% displayed a decreasing 
trend in Young’s Modulus.  
 
** statistical significance, p < 0.05, * statistically significant than ** values, p < 0.05.     
Figure 2.3 - Young’s modulus of PEG hydrogels with varying concentrations of adECM 
additives.   
 
 
2.4.5  Swelling and Mass Loss 
       Scaffolds containing adECM were assessed for changes in swelling, mesh size, and 
mass-loss during incubation.  Hydrogel swell ratio over the course of 168 hours is 
displayed in Figure 2.4.  Scaffolds containing 1% adECM showed increased swelling size 
between 120 and 168 hours compared to all other scaffold samples.  There were no 
significant differences in swell ratio noted among scaffolds containing 0%, 0.01%, and 
0.1% adECM across all recorded time points.  Scaffold mass loss was evaluated up to 
168 hours (Figure 2.5).  From 12 to 120 hours, hydrogels containing 1% adECM exhibited 
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mass loss to the greatest extent compared to all other scaffold samples.  At 168 hours, 
hydrogels containing 1% adECM showed increased mass loss compared to scaffold 
groups containing 0% and 0.1% adECM.  At 24 and 48 hours, hydrogels containing 0.1% 
adECM displayed greater mass loss compared to samples containing 0.01% adECM, 
however, at 168 hours, scaffolds containing 0.01% adECM showed increased mass loss 
compared to 0.1% adECM samples. 
 
Figure 2.4 - Swelling ratio for PEG hydrogels with varying concentrations of adECM 
additives expressed over an incubation period of 168 hours.  Error bars shown.  1% 
adECM hydrogel was found to have a significantly higher swell ratio at 168 hours than 





Figure 2.5 - Mass loss of PEG hydrogels containing varying concentrations of adECM 
additives expressed as percent lost over an incubation time of 168 hours.  1% adEM 
hydrogels displayed significantly increased mass loss compared to all other samples at 
12, 24, 48, 72, and 120 hours.  At 168 hours, 1% adECM hydrogels displayed significantly 




2.4.6  hASC Viability After Exposure to Scaffold Extracts 
       Viability of hASCs following exposure to hydrogel extracts is shown in Figure 2.6.  
Compared to cells cultured in stromal media, hASCs exposed to extracts of scaffolds 
containing 0%, 0.01%, 0.1%, and 1% adECM displayed no significant difference in 
viability at both 7-day and 14-day time points.    
 
Figure 2.6 - Cell viability for PEG extracts with varying concentrations of adECM additives. 
Extracts were taken after either 7 or 14 days of incubation. Values were normalized to a 
live control of hASCs cultured in stromal media.  
  
2.4.7  hASC Morphology and DNA Synthesis 
       Corresponding confocal imaging of hASCs (Figure 2.7 and Figure 2.8) showed cells 
encapsulated in Matrigel® to have a greater number of protrusions than those cultured in 
PEG-based scaffolds at 7 days.  At 14 days, hASCs cultured in Matrigel® displayed more 
aligned, stretched and organized development of F-actin in comparison to PEG-based 
scaffolds.  Qualitatively, no significant cellular morphological changes were appreciated 
within adECM hydrogel groups between 7 and 14 days.  Image analysis using DRAQ5 
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and EdU staining indicated significant cellular proliferation rates for only Matrigel® 


































Figure 2.7 - Images acquired at 7 days using Leica SP8. Scale bars = 50 µm. hASCs 
encapsulated in Matrigel® samples stained with DRAQ5 (Blue) (A) and F-Actin (Green) 
(A’’) exhibited a greater number of protrusions compared to cells in 0% adECM (B,B’’), 
0.01% adECM (C,C’’), 0.1% adECM (D,D”), 1% adECM (E,E”) hydrogel samples.  hASCs 
in Matrigel® stained with Edu (Red) (A’) displayed a proliferation rate of (214% ± 34%) 
between 0 and 7 days.  PEG-hydrogel samples did not display significant proliferation 
rates (B’-E’).      
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Figure 2.8 - Images acquired at 14 days using Leica SP8. Scale bars = 50 µm. hASCs 
encapsulated in Matrigel® samples stained with DRAQ5 (Blue) (F) and F-Actin (Green) 
(F’’) demonstrated more aligned, stretched and organized development of F-actin 
compared to cells in 0% adECM (G,G”), 0.01% adECM (H,H”), 0.1% adECM (I,I”), 1% 
adECM (J,J”) hydrogel samples.  hASCs in Matrigel® stained with Edu (Red) (F’) displayed 
a proliferation rate of (288% ± 57%) between 0 and 14 days.  PEG-hydrogel samples did 
not display significant proliferation rates (G’-J’).     
 
 
2.4.8  Quantitative Reverse-transcript PCR of Human Pluripotency Markers 
       Analysis of gene expression markers of pluripotency indicated that 0.1% and 1% 
adECM groups had significantly higher levels of both NANOG (Figure 2.9) and SOX2 
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(Figure 2.10) gene expression compared to Matrigel® and 0% adECM samples at both 7 
and 14 days.  At both time points, there was no significant difference in NANOG or SOX2 
expression between the 0.1% adECM and 1% adECM groups.  
  
** statistical  significance, p < 0.05. 
Figure 2.9 - Relative expression levels of NANOG in Matrigel® and PEG hydrogels with 
adECM additives after 7 and 14 days in culture.    
 
 
    
** statistical  significance, p < 0.05.      
Figure 2.10 - Relative expression levels of SOX2 in Matrigel® and PEG hydrogels with 








2.5  Discussion 
       hASCs were used to evaluate the impact of different adECM compositions in PEG-
acrylate hydrogels on cell behavior.  Corning®® Matrigel® was used as a positive control 
because of its wide use in 3D cell culture.  
        To address the need for a mechanically tunable, cost-effective 3D scaffold that 
supports stem cell viability and maintains cellular potency, adipose was decellularized 
and incorporated with a thiol-acrylate polymer fraction that was then polymerized to 
produce a hydrogel.  Scaffolds of various adECM concentrations were evaluated. ECM 
additives beyond 1% of total volume did not disperse homogeneously, leading to an 
unstable hydrogel. Therefore, experiments were designed to test the physical and 
physicochemical properties of PEG hydrogels with adECM concentrations (w/v) of 0%, 
0.01%, 0.10%, or 1%.   
       Hydrogel swelling is dependent upon the polymer network structure, cross-linking 
density, and hydrophilicity. The equilibrium degree of swelling was experimentally 
determined for each hydrogel. Initial mechanical studies examined the swelling, mass 
loss, and porosity of the hydrogel scaffolds.  Results indicated that the elastic modulus of 
PEG hydrogels with adECM concentrations of 0.01% and 0.10% was not significantly 
different than that of hydrogels containing 0% adECM.  Hydrogels containing 1% adECM 
showed significantly a lower Young’s modulus than all other experimental PEG hydrogels. 
Similarly, 1% adECM hydrogels displayed significantly more rapid rates of mass loss and 
greater degrees of swelling.  We hypothesize that this phenomenon could be caused by 
a greater degree of steric hindrance during polymerization, resulting in less efficient 
crosslinking in hydrogels with higher adECM concentrations.  However, 1% adECM 
hydrogels showed approximately a one hundred-fold increase in elastic modulus 
compared to Matrigel® (450 Pa).120  In addition, the degrees of stiffness of the PEG-
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based hydrogels evaluated in this study were, overall, greater than those of many other 
reported PEG-based hydrogels.121-126    
       After mechanical characterization, subsequent studies focused on assessing hASC 
viability, proliferation, morphology and differentiation capacity upon encapsulation in 
hydrogels containing varying amounts of adECM.  When exposed to hydrogel extracts, 
hASCs exhibited no loss of viability in comparison to growth media controls.  These 
results are in agreement with previous findings from PEG based hydrogel extracts studies 
where mouse fibroblasts (Balb/3T3)) were treated with extracts from PEG-vinyl Sulfone 
hydrogels.126  Characterization utilizing EdU staining assay indicated decreased DNA 
synthesis in adECM hydrogels relative to Matrigel® controls at both 7 and 14 days.  In 
addition, qualitative examination of F-actin and DRAQ5 staining results suggested little 
difference in cellular morphology among PEG hydrogels, but substantial difference at 14 
days between Matrigel® and PEG scaffolds.  Previous studies have shown that cells 
proliferate more rapidly in hydrogels containing immobilized matrix proteins, such as 
RGD. The effects of the adECM additives may have been greater if the matrix proteins 
were bound. In addition, the study found that greater hydrogel stiffness amplified the 
effects of the membrane proteins.127  Therefore, the lower adECM concentrations may 
result in higher cell proliferation due to the effects of matrix stiffness on ECM additives.  
       Finally, RT-qPCR results indicated that cells encapsulated in all PEG hydrogel 
samples initially exhibited significantly higher NANOG and SOX2 expression compared 
to Matrigel® samples, and that hydrogels containing higher concentrations of adECM 
maintained increased expression of both genes at 14 days.  Yu et al. demonstrated that 
hASCs expanded on decellularized adipose tissue microcarriers maintained their 
trilineage differentiataion capacity to a greater extent than those cultured on 
commercially-sourced Cultispher-S microcarriers, suggesting that adipose-derived ECM 
scaffolds may have the ability to conserve mulipotency in hASCs to a larger degree than 
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commonly used commercial scaffold platforms.128  Further studies must be performed 
in order to further confirm the ability of adECM hydrogels to maintain multipotency in 
hASCs.      
       Our work highlights that the addition of adECM to otherwise biologically inactive 
scaffolds can significantly alter the potency potential of encapsulated hASCS.  adECM 
hydrogels have the capability to be further developed for use in multipotency maintenance 
in stem cells.  Tuning the mechanical characteristics, adECM content, and seeding 
density of the platform has the potential to lead to the enhancement of cellular expansion 
and multilineage differentiation capacity.        
2.6  Conclusion 
       Over the course of this study, we decellularized and processed adipose-derived ECM 
in a form usable for a number of tissue engineering applications. adECM was 
incorporated in varying concentrations into a PEG-acrylate hydrogel. Analysis suggested 
that, like Matrigel®, adECM-composite hydrogels provide a microenvironment that is able 
to sustain cell viability. However, the physicochemical and mechanical properties of PEG-
acrylate hydrogels can be easily manipulated and finely tuned to satisfy the needs of 
project-specific applications. Overall, this technology can be versatile for the growth and 
expansion of mesenchymal stem cells.  In addition, adECM can be processed from 
abundant lipoaspirates, which are often discarded as medical waste, providing a low cost 
source of bioactive material for use in scaffold fabrication. Further studies need to be 
conducted to compare cell behavior in the presence of synthetic peptides. We would 
hypothesize that signaling molecules and membrane proteins present in ECM would 
provide a more finely-tuned cell niche than synthetic peptides alone. 
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3.  PRELIMINARY EVALUATION OF HYBRID SYNTHETIC/THIOLATED ADIPOSE-
DERIVED ECM HYDROGELS 
 
3.1  Project Purpose 
       Inspired by the findings that adipose-derived ECM can be converted into a 
cytocompatible hydrogel after combination with a synthetic thiol-acrylate fraction, efforts 
were conducted in order to improve the performance of the hybrid synthetic/adipose-
derived ECM hydrogel platform.  In this study, adipose-derived ECM was thiolated prior 
to hydrogel polymerization via a ring opening polymerization in order to promote more 
uniform dispersion and greater concentration of adECM proteins. adECM was 
incorporated, at varying concentrations, with a synthetic thiol-acrylate fraction that was 
then polymerized to produce hydrogels via a Michael addition reaction, as described in 
Chapter 2 of this thesis.  Hydrogels were characterized based on their stiffness and ability 
to maintain the viability human adipose-derived stem cells (hASCs).  It was found that 
hASCs seeded on hydrogels containing higher concentrations of thiolated adECM 
(tadECM) demonstrated decreased viability compared to tadECM-free hydrogels.  These 
results indicate that tadECM hydrogels may need to be further improved as stem cell 
scaffolds, possibly by increasing tadECM functionality.   
3.2  Introduction  
       The ability to obtain uniformity in scaffold structure has been demonstrated to greatly 
improve stem cell spatial distribution, growth and proliferation. Moreover, it can lead to a 
more committed differentiation pathway.129  Decellularized adipose-derived extracellular 
matrix has been found to induce adipogenesis in hASCs both in vitro and in vivo.113,130  
These scaffolds have been shown to have high concentrations of ECM proteins, however, 
they are relatively mechanically unstable compared to synthetic polymer 
platforms.131,132 
       In this preliminary study, we present a strategy for increasing the ECM content in 
synthetic ECM/PEG hydrogel by using adipose-derived ECM that has been thiolated via 
a ring opening polymerization.  Thiolation efficiency was quantified prior to the synthesis 
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of three hydrogels containing various thiolated adECM (tadECM) compositions.  The 
mechanical properties of hydrogels with different ECM concentrations were 
characterized. In addition, viability of hASCs seeded on the hydrogels was assessed.    
3.3  Materials and Methods 
3.3.1  ECM Decellularization 
       Adipose tissue was decellularized as previously described in Chapter 2 of this thesis, 
briefly, (~100g) was placed in 200 mL of 3.4 M sodium chloride (NaCl) buffer for 1 hour. 
The tissue was then homogenized using an electric homogenizer (Omni Ultra Shear 
Small Volume).  Fibrous tissue that could not be mechanically homogenized 
removed.  100 mL of 2 M urea buffer was then added to the collected fibrous tissue, and 
the solution was refrigerated for 48 hours. The fibrous tissue was centrifuged three times 
at 23,000 g at 4 ̊ C for 20 minutes.    The fibrous pellet was then dialyzed against deionized 
water for 24 hours before digestion with 0.5% (w/v) pepsin in 0.5 M acetic acid.  After 
completion of the digestion reaction, the pepsin was deactivated by raising the pH of the 
solution to 9.0 using 1 M sodium hydroxide (NaOH).  The solution was then incubated 
overnight at 37 ˚C, followed by lowering the pH of the solution to 7.4 with 1 M hydrochloric 
acid (HCl).  The neutralized solution was dialyzed again against deionized water for 24 
hours before being flash-frozen and lyophilized to yield a decellularized, adipose-derived 
extracellular matrix (adECM) powder.  
3.3.2  Protein Quantification  
       The Pierce™ BCA Assay (ThermoFisher Scientific, USA) was used, as described in 
Chapter 2 of this thesis, to determine the total protein content in ECM samples. Diluted 
aliquots of processed ECM (10 μL) were removed (n=3) and incubated with assay 
reagents for 30 min at 37 ℃ in a 96-well plate in accordance with the Pierce™ protocol. 
The plate was then cooled to room temperature and absorbance was measured at 532 




3.3.3 ECM Thiolation 
       adECM was thiolated as previously described.133  Briefly, adECM (80 mg) was 
immersed in 20 mL EtOH: PBS 1:1 (v/v) solution containing 0.033 M γ-thiobutyrolactone 
at room temperature for 24 h.  Then, the pH of the solution was lowered to 5 for 10 min 
using acetic acid (Sigma).  The solution was dialyzed against deionized water overnight, 
then lyophilized.  Thiolation efficiency was calculated using the DTNB colorimetric assay 
(Sigma).  The thiolated adipose-derived ECM (tadECM) powder was sterilized with 
ethylene oxide prior to use in vitro. 
3.3.4  Fabrication of tadECM Hydrogels 
       Hydrogel reagents were reacted together employing a thiol-ene base-catalyzed 
Michael addition reaction with a 1:1 functional group ratio of acrylate to thiol. tadECM 
proteins in phosphate buffered saline (PBS) were preincubated for 30 minutes with PEG-
acrylate monomers. During preincubation, a solution of PBS, ethoxilated-
trimethylolpropan tri(3-mercaptopropionate) (ETTMP 1300, and 1 M NaOH were reacted 
together in a separate tube. After incubation, the PEG-acrylate and adECM solution was 
mixed with the ETTMP 1300 and NaOH solution.  Hydrogels were synthesized at 1: 1: 0, 
1: 0.25: 0.75, 1: 0.5: 0.5 (PEG-acrylate: ETTMP: tadECM) by molar functionality.  Gelation 
occurred in less than one minute, and could be controlled by adjusting the temperature 
and amount of NaOH . 
3.3.5  Mechanical Testing 
       Hydrogels with protein additives (1: 1: 0, 1: 0.25: 0.75, 1: 0.5: 0.5) were formed using 
a 5 mm (height) × 10 mm (diameter) cylindrical mold and allowed to swell overnight before 
being tested to determine elastic modulus and maximal compressive strength.118  The 
results reported (n=5) were taken with 80% strain at a compression rate of 1 mm/min from 
an Instron Mechanical Test System 5696 using an Instron 2 kN static load cell (Instron 




3.3.6  Seeding and Culture of hASCs with Synthetic adECM Hydrogel 
       Hydrogels were formed in a 2 mm (height) x 5 mm (diameter) cylindrical mold before 
being transferred to a 48-well plate and allowed to swell in PBS overnight.  Cells were 
isolated and cultured as described in Chapter 2 of this thesis.  Second passage (P2)  
hASCs were seeded on the hydrogels at a density of 25,000 cells / scaffold.  Cells were 
cultured in growth media (Dulbecco's modified Eagle's medium [DMEM/F12], 10% fetal 
bovine serum [FBS], and 1% Penicillin-Streptomycin-Amphotericin B solution) for 7 days 
with media maintenance performed three times a week. 
3.3.7  Live/Dead® Staining 
       At 7 days, cell viability was assessed using the Live/Dead® viability/cytotoxicity kit 
(Molecular Probes, Eugene, OR).  Each specimen was incubated in a 0.2% ethidium 
homodimer, 0.05% calcein am (v/v) solution in PBS (-Ca, -Mg), protected from light, for 
45 min. Cells were visualized via fluorescence microscopy (Zeiss Stereo Lumar) in 
combination with a digital camera (Hamamatsu Orca ER cooled CCD).  
3.3.8  Statistical Analysis 
       All results were expressed as mean ± standard deviation. Data were analyzed with 
one-way analysis of variance, followed by Tukey's minimum significant difference post 
hoc test for pairwise comparisons of main effects. For all comparisons, a p-value < 0.05 
was considered significant. 
3.4  Results 
3.4.1  adECM Thiolation and Hydrogel Synthesis 
       In this study, the effects of tadECM hydrogels on hASCs were evaluated. A 
schematic for adECM thioaltion and hydrogel polymerization is presented in Scheme 3.1 
and Scheme 3.2, respectively.  tadECM thiolation effiency, as evaluated using the DTNB 
assay, was reported to be 248.7 µmol / g ± 1.6 µmol / g.  For comparison, unmodified 
adECM was found to have a thiol concentration of 104.2 µmol / g ± .6 µmol / g.   
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Scheme 3.2 - Synthesis of tadECM hydrogel using tadECM, 4-arm PEG acrylate, and 
ETTMP.  Reaction was catalyzed using sodium hydroxide.  
 
3.4.2  Mechanical Characterization 
       Figure 3.1 shows the mechanical strength for hydrogel scaffolds containing different 
















between hydrogel the 1: 1: 0 and 1: 0.75: 0.25 formulation groups.  A significant difference 
in Young’s modulus was observed between the 1: 0.5: 0.5 hydrogel formulation group 
and the 1: 1: 0 and 1: 0.25: 0.75 groups.    
 
 
** statistical significance, p < 0.05. 




 3.4.3  hASC Viability  
       Figure 3.2 shows hASCs stained with the Live/Dead® staining kit at 7 days.  
Qualitatively, hASCs seeded on 1: 1: 0 hydrogels exhibited greater viability at 7 days than 
cells seeded on either 1: 0.25: 0.75 or 1: 0.5: 0.5 scaffolds.  In addition, cells appeared to 
remain adhered to the surface of the 1: 1: 0 formulation hydrogel compared to either the 
1: 0.25: 0.75 or 1: 0.5: 0.5 groups.   
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Figure 3.2 - Scale bar = 150 µm.   tadECM hydrogels stained with Live/Dead®  kit.   
 
 
3.5  Discussion 
 
       adECM was thiolated prior to incorporation with a PEG-acrylate/ETTMP polymer 
fraction to produce a hydrogel.  tadECM thiolation was found to be 248.7 µmol / g ± 1.6 
µmol / g.  This degree of substitution is comparable to the results of Xu et. al, who 
demonstrated an experimental collagen thiolation efficiency of 297 µmol / g ± 1.6 µmol / 
g.134  
       Mechanical characterization of 1: 1: 0, 1: 0.5: 0.5, and 1: 0.25: 0.75 tadECM hydrogel 
groups demonstrated that a decrease in Young’s modulus correlated with an increase in 
tadECM content and a decrease in ETTMP concentration.  This may due to a lower 
conversion rate for hydrogel groups with high concentrations of tadECM. Similarly, Artzi 
et. al found that incomplete monomer conversion was responsible for decreased 
mechanical strength.135   
       Finally, Live/Dead® staining of tadECM hydrogels revealed that decreased cell 
viability correlated with increased tadCM content and decreased ETTMP concentration.  
These results could be caused by unreacted acrylate groups, which have been found to 
be relatively cytotoxic in vitro.136   
       Overall, the results of this preliminary study indicated that more complete thiol-
acrylate conversion in hydrogel synthesis should be obtained in order to improve both 
the mechanical and cytocompatibility properties of the tadECM scaffold.  This may be 
1	:	0:	1	 1:	0.25:	0.75 1:	0.5:	0.5	 
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addressed thiolating adECM to a greater degree by, first, increasing the amount of 
lysines present in the protein structure.  Xu et. al was able to accomplish this goal by 
subjecting collagen to a carboxylation reaction, followed by an amidation reaction with 
2-mercaptoethylamine hydrochloride (MEA) and a EDC-NHS  (EDC: 1-(3-
dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride; NHS: N-hydroxysuccinimide) 
condensation reaction.134  
3.6  Conclusion  
       In this study, we successfully thiolated adECM and synthesized a hybrid 
synthetic/tadECM hydrogel.  However, mechanical and cytocompatibility studies revealed 
that reduced Young’s modulus and cell viability correlated with increased tadECM 
content.  As these results may be caused by incomplete thiol-acryalte conversion, future 
work will focus on improving tadECM functionality.  We would hypothesize that increasing 
the number of tadECM thiol functional groups would lead to improved outcomes.  
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4. SUMMARY, CONCLUSIONS, AND RECOMMENDATIONS 
4.1  Summary 
       ECM-based hybrid hydrogels are currently being used in the field of tissue 
engineering to in an effort to promote stem cell proliferation and differentiation.  In these 
studies, hybrid synthetic/adipose-derived ECM scaffolds were characterized based on 
their mechanical properties and ability to support hASC proliferation, viability and 
multipotency preservation. 
       Inspired by the findings that adipose-derived ECM can be converted into a 
cytocompatible hydrogel after combination with a synthetic fraction, efforts were 
conducted in order to improve the performance of the hybrid synthetic/adipose-derived 
ECM hydrogel platform.  ECM was thiolated prior to hydrogel synthesis in order to 
promote more uniform dispersion. Thiolated adipose-derived ECM hydrogels were 
characterized based on their elasticity and ability to maintain hASC viability. 
4.2  Conclusions 
       hASCs encapsulated in hybrid synthetic/adipose-derived ECM hydrogels 
containing high concentrations of ECM demonstrated greater expression of human 
potency markers compared to cells encapsulated in ECM-free synthetic hydrogels or in 
Matrigel®.  These results indicate that adECM hydrogels hold promise as a cost-
effective platform for hASC multipotency maintenance in tissue engineering 
applications.   
       It was found that hASCs seeded on synthetic hybrid hydrogels containing higher 
concentrations of thiolated adECM (tadECM) demonstrated decreased viability compared 
to tadECM-free hydrogels.  As these results may be caused by incomplete thiol-acrylate 
conversion, increasing the thiol concentration of the tadECM prior to hydrogel synthesis 





4.3  Recommendations  
1. Further validation of the multipotency maintenance capability adECM hydrogels is 
needed to evaluate their potential as stem cells scaffolds.  
2. Studies investigating the ability of hybrid adECM hydrogels to affect hASC 
trilineage differentiation are needed in order to asses their capacity to facilitate 
tissue regeneration.  Additives, such as β-TCP, hydroxyapatite, TGF- β3, or BMP-
6, may assist in promoting a specific stem cell lineage. 
3. Enhanced adECM dispersion in the hydrogels may improve stem cell spatial 
distribution and proliferation.  It may also lead to a more committed differentiation 
pathway.  This may be achieved by increasing the thiol concentration of the 
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